*Corresponding author:
Chonkar Sonali, Staff Physician, KK Women’s and Children’s Hospital, SingaporeReceived: April 07, 2018; Published: April 23, 2018
DOI: 10.26717/BJSTR.2018.04.000989
To view the Full Article Peer-reviewed Article PDF
Pregnancy has been known to put women in a hypercoagulable state. This has been postulated to be the body’s physiological response to the maternal’s susceptibility to bleeding risks during the antenatal and postnatal period [1-3]. Thus, pregnant women are four to five times more likely to develop venous thromboembolism (VTE) [4], putting the incidence to about 0.71 per 1000 pregnancies [4]. VTE is known to affect pregnant women from 1st trimester up to post partum [5] with the risk of VTE being higher as the woman progresses later in her pregnancy [6]. VTE in pregnancy is also more known to affect the left lower limb than the right, with a weighted event rate of 77.2% for left sided or bilateral lower limb deep vein thrombosis and 21.5% for right sided deep vein thrombosis [5]./p>
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China